Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same

Details for Australian Patent Application No. 2011203238 (hide)

Owner Novartis AG

Inventors Cao, Yu; Joshi, Yatindra; Li, Ping; Pudipeddi, Madhusudhan; Royce, Alan Edward; Wagner, Robert Frank; Zhu, Jiahao

Agent Davies Collison Cave

Pub. Number AU-A-2011203238

Parent 2007265138

Filing date 1 July 2011

Wipo publication date 21 July 2011

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/549 (2006.01) - having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

14 July 2011 Complete Application Filed

21 July 2011 Application Open to Public Inspection

  Published as AU-A-2011203238

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011203239-Mineral particle material resolving X-ray imaging

2011203237-Patient selectable knee joint arthroplasty devices